128 related articles for article (PubMed ID: 18755512)
1. Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity.
Reithofer MR; Schwarzinger A; Valiahdi SM; Galanski MS; Jakupec MA; Keppler BK
J Inorg Biochem; 2008 Dec; 102(12):2072-7. PubMed ID: 18755512
[TBL] [Abstract][Full Text] [Related]
2. Novel endothall-containing platinum(IV) complexes: synthesis, characterization, and cytotoxic activity.
Reithofer MR; Valiahdi SM; Galanski M; Jakupec MA; Arion VB; Keppler BK
Chem Biodivers; 2008 Oct; 5(10):2160-2170. PubMed ID: 18972539
[TBL] [Abstract][Full Text] [Related]
3. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
[TBL] [Abstract][Full Text] [Related]
4. Mono-carboxylated diaminedichloridoplatinum(IV) complexes--selective synthesis, characterization, and cytotoxicity.
Pichler V; Valiahdi SM; Jakupec MA; Arion VB; Galanski MS; Keppler BK
Dalton Trans; 2011 Aug; 40(32):8187-92. PubMed ID: 21743934
[TBL] [Abstract][Full Text] [Related]
5. Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination.
Reithofer MR; Valiahdi SM; Jakupec MA; Arion VB; Egger A; Galanski MS; Keppler BK
J Med Chem; 2007 Dec; 50(26):6692-9. PubMed ID: 18031001
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin.
Varbanov H; Valiahdi SM; Legin AA; Jakupec MA; Roller A; Galanski MS; Keppler BK
Eur J Med Chem; 2011 Nov; 46(11):5456-64. PubMed ID: 21940073
[TBL] [Abstract][Full Text] [Related]
7. Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2012 Sep; 9(9):1840-8. PubMed ID: 22976974
[TBL] [Abstract][Full Text] [Related]
8. A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.
Varbanov HP; Göschl S; Heffeter P; Theiner S; Roller A; Jensen F; Jakupec MA; Berger W; Galanski MS; Keppler BK
J Med Chem; 2014 Aug; 57(15):6751-64. PubMed ID: 25032896
[TBL] [Abstract][Full Text] [Related]
9. Bulky N(,N)-(di)alkylethane-1,2-diamineplatinum(II) compounds as precursors for generating unsymmetrically substituted platinum(IV) complexes.
Pichler V; Göschl S; Meier SM; Roller A; Jakupec MA; Galanski MS; Keppler BK
Inorg Chem; 2013 Jul; 52(14):8151-62. PubMed ID: 23790208
[TBL] [Abstract][Full Text] [Related]
10. Tetracarboxylatoplatinum(IV) complexes featuring monodentate leaving groups - A rational approach toward exploiting the platinum(IV) prodrug strategy.
Höfer D; Varbanov HP; Legin A; Jakupec MA; Roller A; Galanski MS; Keppler BK
J Inorg Biochem; 2015 Dec; 153():259-271. PubMed ID: 26365319
[TBL] [Abstract][Full Text] [Related]
11. Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.
Varbanov HP; Valiahdi SM; Kowol CR; Jakupec MA; Galanski MS; Keppler BK
Dalton Trans; 2012 Dec; 41(47):14404-14415. PubMed ID: 22886297
[TBL] [Abstract][Full Text] [Related]
12. Impact of the equatorial coordination sphere on the rate of reduction, lipophilicity and cytotoxic activity of platinum(IV) complexes.
Höfer D; Varbanov HP; Hejl M; Jakupec MA; Roller A; Galanski MS; Keppler BK
J Inorg Biochem; 2017 Sep; 174():119-129. PubMed ID: 28666155
[TBL] [Abstract][Full Text] [Related]
13. Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes.
Reithofer MR; Bytzek AK; Valiahdi SM; Kowol CR; Groessl M; Hartinger CG; Jakupec MA; Galanski MS; Keppler BK
J Inorg Biochem; 2011 Jan; 105(1):46-51. PubMed ID: 21134601
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand.
Galanski MS; Slaby S; Jakupec MA; Keppler BK
J Med Chem; 2003 Nov; 46(23):4946-51. PubMed ID: 14584945
[TBL] [Abstract][Full Text] [Related]
15. Novel cis- and trans-configured bis(oxime)platinum(II) complexes: synthesis, characterization, and cytotoxic activity.
Scaffidi-Domianello YY; Meelich K; Jakupec MA; Arion VB; Kukushkin VY; Galanski MS; Keppler BK
Inorg Chem; 2010 Jun; 49(12):5669-78. PubMed ID: 20459062
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterisation and potent cytotoxicity of unconventional platinum(iv) complexes with modified lipophilicity.
Deo KM; Sakoff J; Gilbert J; Zhang Y; Aldrich Wright JR
Dalton Trans; 2019 Nov; 48(46):17217-17227. PubMed ID: 31729519
[TBL] [Abstract][Full Text] [Related]
17. Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.
Scaffidi-Domianello YY; Legin AA; Jakupec MA; Roller A; Kukushkin VY; Galanski MS; Keppler BK
Inorg Chem; 2012 Jul; 51(13):7153-63. PubMed ID: 22691006
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine.
Harringer S; Hejl M; Enyedy ÉA; Jakupec MA; Galanski MS; Keppler BK; Dyson PJ; Varbanov HP
Dalton Trans; 2021 Jun; 50(23):8167-8178. PubMed ID: 34031671
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic Acid.
Zmejkovski BB; Pantelić N; Filipović L; Aranđelović S; Radulović S; Sabo TJ; Kaluđerović GN
Anticancer Agents Med Chem; 2017; 17(8):1136-1143. PubMed ID: 27928952
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes.
Savić A; Filipović L; Aranđelović S; Dojčinović B; Radulović S; Sabo TJ; Grgurić-Šipka S
Eur J Med Chem; 2014 Jul; 82():372-84. PubMed ID: 24927057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
